A popular axiom among long-only investors is to “buy low sell high.” For those investors who are equally interested in making money from both markets going up and markets going down, the parallel axiom is, “short-sell high and buy-to-cover low.” In the short-term, the stock market is overbought, and it
In 1971, a Japanese biochemist, Akira Endo, started work on what turned out to be the next big thing in the prevention of heart attacks and strokes, known as statins. In 1978, Merck (MRK) isolated lovastatin from fungusAspergillus terreus. Lovastatin is naturally contained in red yeast rice, a traditional Chinese fermented rice
Our methodology correctly predicted conditions at MRK as is evidenced by its earnings this morning. Consider start taking partial profits in $23.00 to $23.20 range or higher, depending on the size of your position. If the stock falls further consider to continue to take profits. www.thearorareport.com THE ARORA REPORT, Ltd.
Merck had the best two day gain ever in its history. After a 38% gain, this afternoon smart money was selling in the wake of massive short covering as measured by our proprietary studies. The initial trigger to the upside today was an analyst upgrade. Nothing fundamental has changed in